Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
24-Week Randomized Double-Blind Placebo-Controlled Study of OPN-375 (Fluticasone Propionate) in Chronic Sinusitis
2019-000368-12Phase 3Unknown
- Sponsor
- OptiNose
- Start
- Apr 2019
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of fluticasone propionate in rhinosinusitis (3 arms), sponsored by OptiNose. Primary endpoint: Co-primary efficacy endpoints. Status: unknown.
02
Drugs
fluticasone propionate
03
Conditions
rhinosinusitis
Beyond the preview
Go deeper on 2019-000368-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-000368-12.